J CARDIOTHORAC SURG 润色咨询

Journal of Cardiothoracic Surgery

出版年份：2006 年文章数：2330 投稿命中率： 开通期刊会员，数据随心看

出版周期：Irregular 自引率：2.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0<br>偏重的研究方向：胸心外科<br>经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912112, encodeId=4b839121122f, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：3月份投的，12月还没出结果，巨慢啊巨慢，中间催过一次，不管用……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/60812c3f0fc54515957255d137b01318/3de2cfce875341939bed281c9b1cc164.jpg, createdBy=79ed1927012, createdName=蜡笔小新，，, createdTime=Wed Dec 30 10:37:35 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970378, encodeId=06399e0378c6, content=投稿比较顺利，整体效率还是挺高的，去年正好赶上疫情，杂志社还给延长了返修期限。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAV5SXKLVxD0wsrAKQuFjStpKOWR8PN5fovkCOeBAPGSibk9j2pQpKkpkjJ858ofsShAL0DswIQMA/0, createdBy=76ec2203305, createdName=混饭吃的小大夫, createdTime=Wed Jun 02 17:13:42 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809271, encodeId=848d8092e13d, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>写了一篇关于食管鳞癌预后的文章，用了两个血液指标，2020.01.27投稿，4月30日返修，给的大修，三个reviewer，一个接收，一个小修，一个拒稿，最后是大修。一周内提交revised manuscript，5.18接收，一周左右online。投的第一次，中了，中稿率算100%吗？哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=636, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=Lei-Lei, createdTime=Sat Aug 15 22:54:41 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0<br>经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管<br>经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管<br>经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102048, encodeId=5ae11102048a1, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-09-29 1463b3a1m11暂无昵称

    完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼)

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0<br>偏重的研究方向：胸心外科<br>经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912112, encodeId=4b839121122f, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：3月份投的，12月还没出结果，巨慢啊巨慢，中间催过一次，不管用……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/60812c3f0fc54515957255d137b01318/3de2cfce875341939bed281c9b1cc164.jpg, createdBy=79ed1927012, createdName=蜡笔小新，，, createdTime=Wed Dec 30 10:37:35 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970378, encodeId=06399e0378c6, content=投稿比较顺利，整体效率还是挺高的，去年正好赶上疫情，杂志社还给延长了返修期限。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAV5SXKLVxD0wsrAKQuFjStpKOWR8PN5fovkCOeBAPGSibk9j2pQpKkpkjJ858ofsShAL0DswIQMA/0, createdBy=76ec2203305, createdName=混饭吃的小大夫, createdTime=Wed Jun 02 17:13:42 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809271, encodeId=848d8092e13d, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>写了一篇关于食管鳞癌预后的文章，用了两个血液指标，2020.01.27投稿，4月30日返修，给的大修，三个reviewer，一个接收，一个小修，一个拒稿，最后是大修。一周内提交revised manuscript，5.18接收，一周左右online。投的第一次，中了，中稿率算100%吗？哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=636, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=Lei-Lei, createdTime=Sat Aug 15 22:54:41 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0<br>经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管<br>经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管<br>经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102048, encodeId=5ae11102048a1, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-10-06 14878573m53(暂无昵称)

    审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0
    偏重的研究方向：胸心外科
    经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0<br>偏重的研究方向：胸心外科<br>经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912112, encodeId=4b839121122f, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：3月份投的，12月还没出结果，巨慢啊巨慢，中间催过一次，不管用……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/60812c3f0fc54515957255d137b01318/3de2cfce875341939bed281c9b1cc164.jpg, createdBy=79ed1927012, createdName=蜡笔小新，，, createdTime=Wed Dec 30 10:37:35 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970378, encodeId=06399e0378c6, content=投稿比较顺利，整体效率还是挺高的，去年正好赶上疫情，杂志社还给延长了返修期限。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAV5SXKLVxD0wsrAKQuFjStpKOWR8PN5fovkCOeBAPGSibk9j2pQpKkpkjJ858ofsShAL0DswIQMA/0, createdBy=76ec2203305, createdName=混饭吃的小大夫, createdTime=Wed Jun 02 17:13:42 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809271, encodeId=848d8092e13d, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>写了一篇关于食管鳞癌预后的文章，用了两个血液指标，2020.01.27投稿，4月30日返修，给的大修，三个reviewer，一个接收，一个小修，一个拒稿，最后是大修。一周内提交revised manuscript，5.18接收，一周左右online。投的第一次，中了，中稿率算100%吗？哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=636, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=Lei-Lei, createdTime=Sat Aug 15 22:54:41 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0<br>经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管<br>经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管<br>经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102048, encodeId=5ae11102048a1, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2020-12-30 蜡笔小新，，

    审稿速度:12.0 | 投稿命中率:50.0
    经验分享：3月份投的，12月还没出结果，巨慢啊巨慢，中间催过一次，不管用……

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0<br>偏重的研究方向：胸心外科<br>经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912112, encodeId=4b839121122f, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：3月份投的，12月还没出结果，巨慢啊巨慢，中间催过一次，不管用……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/60812c3f0fc54515957255d137b01318/3de2cfce875341939bed281c9b1cc164.jpg, createdBy=79ed1927012, createdName=蜡笔小新，，, createdTime=Wed Dec 30 10:37:35 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970378, encodeId=06399e0378c6, content=投稿比较顺利，整体效率还是挺高的，去年正好赶上疫情，杂志社还给延长了返修期限。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAV5SXKLVxD0wsrAKQuFjStpKOWR8PN5fovkCOeBAPGSibk9j2pQpKkpkjJ858ofsShAL0DswIQMA/0, createdBy=76ec2203305, createdName=混饭吃的小大夫, createdTime=Wed Jun 02 17:13:42 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809271, encodeId=848d8092e13d, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>写了一篇关于食管鳞癌预后的文章，用了两个血液指标，2020.01.27投稿，4月30日返修，给的大修，三个reviewer，一个接收，一个小修，一个拒稿，最后是大修。一周内提交revised manuscript，5.18接收，一周左右online。投的第一次，中了，中稿率算100%吗？哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=636, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=Lei-Lei, createdTime=Sat Aug 15 22:54:41 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0<br>经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管<br>经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管<br>经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102048, encodeId=5ae11102048a1, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-06-02 混饭吃的小大夫

    投稿比较顺利，整体效率还是挺高的，去年正好赶上疫情，杂志社还给延长了返修期限。

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0<br>偏重的研究方向：胸心外科<br>经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912112, encodeId=4b839121122f, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：3月份投的，12月还没出结果，巨慢啊巨慢，中间催过一次，不管用……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/60812c3f0fc54515957255d137b01318/3de2cfce875341939bed281c9b1cc164.jpg, createdBy=79ed1927012, createdName=蜡笔小新，，, createdTime=Wed Dec 30 10:37:35 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970378, encodeId=06399e0378c6, content=投稿比较顺利，整体效率还是挺高的，去年正好赶上疫情，杂志社还给延长了返修期限。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAV5SXKLVxD0wsrAKQuFjStpKOWR8PN5fovkCOeBAPGSibk9j2pQpKkpkjJ858ofsShAL0DswIQMA/0, createdBy=76ec2203305, createdName=混饭吃的小大夫, createdTime=Wed Jun 02 17:13:42 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809271, encodeId=848d8092e13d, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>写了一篇关于食管鳞癌预后的文章，用了两个血液指标，2020.01.27投稿，4月30日返修，给的大修，三个reviewer，一个接收，一个小修，一个拒稿，最后是大修。一周内提交revised manuscript，5.18接收，一周左右online。投的第一次，中了，中稿率算100%吗？哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=636, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=Lei-Lei, createdTime=Sat Aug 15 22:54:41 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0<br>经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管<br>经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管<br>经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102048, encodeId=5ae11102048a1, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2020-08-15 Lei-Lei

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享：#肿瘤#写了一篇关于食管鳞癌预后的文章，用了两个血液指标，2020.01.27投稿，4月30日返修，给的大修，三个reviewer，一个接收，一个小修，一个拒稿，最后是大修。一周内提交revised manuscript，5.18接收，一周左右online。投的第一次，中了，中稿率算100%吗？哈哈哈

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0<br>偏重的研究方向：胸心外科<br>经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912112, encodeId=4b839121122f, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：3月份投的，12月还没出结果，巨慢啊巨慢，中间催过一次，不管用……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/60812c3f0fc54515957255d137b01318/3de2cfce875341939bed281c9b1cc164.jpg, createdBy=79ed1927012, createdName=蜡笔小新，，, createdTime=Wed Dec 30 10:37:35 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970378, encodeId=06399e0378c6, content=投稿比较顺利，整体效率还是挺高的，去年正好赶上疫情，杂志社还给延长了返修期限。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAV5SXKLVxD0wsrAKQuFjStpKOWR8PN5fovkCOeBAPGSibk9j2pQpKkpkjJ858ofsShAL0DswIQMA/0, createdBy=76ec2203305, createdName=混饭吃的小大夫, createdTime=Wed Jun 02 17:13:42 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809271, encodeId=848d8092e13d, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>写了一篇关于食管鳞癌预后的文章，用了两个血液指标，2020.01.27投稿，4月30日返修，给的大修，三个reviewer，一个接收，一个小修，一个拒稿，最后是大修。一周内提交revised manuscript，5.18接收，一周左右online。投的第一次，中了，中稿率算100%吗？哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=636, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=Lei-Lei, createdTime=Sat Aug 15 22:54:41 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0<br>经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管<br>经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管<br>经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102048, encodeId=5ae11102048a1, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-12-26 mymartin123

    审稿速度:12.0
    经验分享：慎投

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0<br>偏重的研究方向：胸心外科<br>经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912112, encodeId=4b839121122f, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：3月份投的，12月还没出结果，巨慢啊巨慢，中间催过一次，不管用……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/60812c3f0fc54515957255d137b01318/3de2cfce875341939bed281c9b1cc164.jpg, createdBy=79ed1927012, createdName=蜡笔小新，，, createdTime=Wed Dec 30 10:37:35 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970378, encodeId=06399e0378c6, content=投稿比较顺利，整体效率还是挺高的，去年正好赶上疫情，杂志社还给延长了返修期限。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAV5SXKLVxD0wsrAKQuFjStpKOWR8PN5fovkCOeBAPGSibk9j2pQpKkpkjJ858ofsShAL0DswIQMA/0, createdBy=76ec2203305, createdName=混饭吃的小大夫, createdTime=Wed Jun 02 17:13:42 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809271, encodeId=848d8092e13d, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>写了一篇关于食管鳞癌预后的文章，用了两个血液指标，2020.01.27投稿，4月30日返修，给的大修，三个reviewer，一个接收，一个小修，一个拒稿，最后是大修。一周内提交revised manuscript，5.18接收，一周左右online。投的第一次，中了，中稿率算100%吗？哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=636, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=Lei-Lei, createdTime=Sat Aug 15 22:54:41 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0<br>经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管<br>经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管<br>经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102048, encodeId=5ae11102048a1, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-07-18 ms6000000719507605

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向：心血管
    经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0<br>偏重的研究方向：胸心外科<br>经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912112, encodeId=4b839121122f, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：3月份投的，12月还没出结果，巨慢啊巨慢，中间催过一次，不管用……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/60812c3f0fc54515957255d137b01318/3de2cfce875341939bed281c9b1cc164.jpg, createdBy=79ed1927012, createdName=蜡笔小新，，, createdTime=Wed Dec 30 10:37:35 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970378, encodeId=06399e0378c6, content=投稿比较顺利，整体效率还是挺高的，去年正好赶上疫情，杂志社还给延长了返修期限。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAV5SXKLVxD0wsrAKQuFjStpKOWR8PN5fovkCOeBAPGSibk9j2pQpKkpkjJ858ofsShAL0DswIQMA/0, createdBy=76ec2203305, createdName=混饭吃的小大夫, createdTime=Wed Jun 02 17:13:42 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809271, encodeId=848d8092e13d, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>写了一篇关于食管鳞癌预后的文章，用了两个血液指标，2020.01.27投稿，4月30日返修，给的大修，三个reviewer，一个接收，一个小修，一个拒稿，最后是大修。一周内提交revised manuscript，5.18接收，一周左右online。投的第一次，中了，中稿率算100%吗？哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=636, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=Lei-Lei, createdTime=Sat Aug 15 22:54:41 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0<br>经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管<br>经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管<br>经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102048, encodeId=5ae11102048a1, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-10-25 1463b3a1m11暂无昵称

    偏重的研究方向：心血管
    经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0<br>偏重的研究方向：胸心外科<br>经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912112, encodeId=4b839121122f, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：3月份投的，12月还没出结果，巨慢啊巨慢，中间催过一次，不管用……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/60812c3f0fc54515957255d137b01318/3de2cfce875341939bed281c9b1cc164.jpg, createdBy=79ed1927012, createdName=蜡笔小新，，, createdTime=Wed Dec 30 10:37:35 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970378, encodeId=06399e0378c6, content=投稿比较顺利，整体效率还是挺高的，去年正好赶上疫情，杂志社还给延长了返修期限。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAV5SXKLVxD0wsrAKQuFjStpKOWR8PN5fovkCOeBAPGSibk9j2pQpKkpkjJ858ofsShAL0DswIQMA/0, createdBy=76ec2203305, createdName=混饭吃的小大夫, createdTime=Wed Jun 02 17:13:42 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809271, encodeId=848d8092e13d, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>写了一篇关于食管鳞癌预后的文章，用了两个血液指标，2020.01.27投稿，4月30日返修，给的大修，三个reviewer，一个接收，一个小修，一个拒稿，最后是大修。一周内提交revised manuscript，5.18接收，一周左右online。投的第一次，中了，中稿率算100%吗？哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=636, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=Lei-Lei, createdTime=Sat Aug 15 22:54:41 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0<br>经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管<br>经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管<br>经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102048, encodeId=5ae11102048a1, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-01-21 1551f63e90m

    Reviews Completed 要多长时间，已经一个月了

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2090969, encodeId=e4c4209096941, content=完了，你们都是一个审稿意见回来就给你们发邮件了，那我网站上看到了一个审稿意见回来，但是没给我发邮件，不会是审稿人拒稿，编辑等别的审稿人意见吧(／_＼), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Thu Sep 29 10:34:58 CST 2022, time=2022-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058037, encodeId=f65b105803e4e, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2490.0<br>偏重的研究方向：胸心外科<br>经验分享：个案一篇反复被拒绝反复投，有1年半时间了。今年6月24日投该杂志社，8月13日修回，审稿人意见不统一，一审稿人接受，一审稿人拒绝，感谢编辑给了修回机会，各种查文章，把其他疾病中的观点借鉴到文中，提出该病尚无人提出的观点，再次提交。编辑很重视格式，因为格式问题给我退回3次后才复审。9月25日告知已接收。10月1日交版面费。现在等着见刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3f75305961, createdName=14878573m53(暂无昵称), createdTime=Wed Oct 06 08:20:51 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912112, encodeId=4b839121122f, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：3月份投的，12月还没出结果，巨慢啊巨慢，中间催过一次，不管用……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/60812c3f0fc54515957255d137b01318/3de2cfce875341939bed281c9b1cc164.jpg, createdBy=79ed1927012, createdName=蜡笔小新，，, createdTime=Wed Dec 30 10:37:35 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970378, encodeId=06399e0378c6, content=投稿比较顺利，整体效率还是挺高的，去年正好赶上疫情，杂志社还给延长了返修期限。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKAV5SXKLVxD0wsrAKQuFjStpKOWR8PN5fovkCOeBAPGSibk9j2pQpKkpkjJ858ofsShAL0DswIQMA/0, createdBy=76ec2203305, createdName=混饭吃的小大夫, createdTime=Wed Jun 02 17:13:42 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809271, encodeId=848d8092e13d, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>写了一篇关于食管鳞癌预后的文章，用了两个血液指标，2020.01.27投稿，4月30日返修，给的大修，三个reviewer，一个接收，一个小修，一个拒稿，最后是大修。一周内提交revised manuscript，5.18接收，一周左右online。投的第一次，中了，中稿率算100%吗？哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=636, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/c69458c5aae644fca7458ac4ee7d3dc5/97598ec05e2943409cd351605fd99203.jpg, createdBy=75b92509278, createdName=Lei-Lei, createdTime=Sat Aug 15 22:54:41 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107514, encodeId=63b1210e51447, content=审稿速度:12.0<br>经验分享：慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e4e2138685, createdName=mymartin123, createdTime=Mon Dec 26 15:54:10 CST 2022, time=2022-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1233240, encodeId=230e1233240f1, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向：心血管<br>经验分享：第一次投，3月4号投稿，4月18回来了一个reviewer和editor给了major revision的decision，5月4号返修，5月23号under review，现在是7-18日，依旧处于review状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=825d5719916, createdName=ms6000000719507605, createdTime=Mon Jul 18 18:24:08 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2096113, encodeId=561e209611302, content=偏重的研究方向：心血管<br>经验分享：这杂志巨慢巨慢，审稿完显示已经收到足够外审意见，但是编辑觉得做了1个月还是没有信，真的是无语了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/23/fa186db585cef81d11691d5c2776a571.jpg, createdBy=da6e5122497, createdName=1463b3a1m11暂无昵称, createdTime=Tue Oct 25 20:26:04 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918614, encodeId=9cf79186146f, content=Reviews Completed 要多长时间，已经一个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9992099710, createdName=1551f63e90m, createdTime=Thu Jan 21 08:26:01 CST 2021, time=2021-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102048, encodeId=5ae11102048a1, content=整理结果过程中，需要按照什么样的逻辑顺序整理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-12-29 msSSSSSD

    整理结果过程中，需要按照什么样的逻辑顺序整理？

    1

    展开1条回复
共54条页码: 1/6页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分